Evidence map›Paper›PMID 38815996›Full record

ArticleInternational health2025

Progress towards the elimination of trachoma in Nigeria.

Caleb D Mpyet, Nicholas Olobio, Sunday Isiyaku, Teyil Wamyil-Mshelia, Grace Ajege, Christopher Ogoshi, Francisca Olamiju, Ijeoma Achu, Mohammed Dantani Adamu, Nasiru Muhammad and 12 more

Abstract read
In one paragraph

Article in International health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Caleb D MpyetSightsavers, Nigeria Country Office, Kaduna, Nigeria.ORCID 0000-0001-8558-9819
Nicholas OlobioDepartment of Public Health, Federal Ministry of Health, Abuja, Nigeria.
Sunday IsiyakuSightsavers, Nigeria Country Office, Kaduna, Nigeria.
Teyil Wamyil-MsheliaSightsavers, Nigeria Country Office, Kaduna, Nigeria.
Grace AjegeSightsavers, Nigeria Country Office, Kaduna, Nigeria.
Christopher OgoshiHealth and Development Support Programme, Jos, Nigeria.
Francisca OlamijuMission to Save the Helpless, Jos, Nigeria.
Ijeoma AchuMission to Save the Helpless, Jos, Nigeria.
Mohammed Dantani AdamuOphthalmology Department, Usmanu Danfodiyo University, Sokoto, Nigeria.
Nasiru MuhammadOphthalmology Department, Usmanu Danfodiyo University, Sokoto, Nigeria.
Aliyu Mohammed JaboHelen Keller International, Abuja, Nigeria.
Philomena OrjiHelen Keller International, Abuja, Nigeria.
Adamani WilliamCBM International, Abuja  Nigeria.
Alice Venyir RamyilDepartment of Ophthalmology, University of Jos, Jos, Nigeria.
Ana BakhtiariTask Force for Global Health, Decatur, GA, USA.
Sarah BoydTask Force for Global Health, Decatur, GA, USA.
Michaela KellySightsavers, Haywards Heath, UK.
Cristina JimenezSightsavers, Haywards Heath, UK.
Amir Bedri KelloWorld Health Organization Regional Office for Africa, Brazzaville, Congo.
Anthony W SolomonGlobal Neglected Tropical Diseases Programme, World Health Organization, Geneva, Switzerland.
Emma M Harding-EschClinical Research Department, London School of Hygiene and Tropical Medicine, London, UK.
Paul CourtrightKilimanjaro Centre for Community Ophthalmology, Division of Ophthalmology, University of Cape Town, Cape Town, South Africa.

Funding

Commonwealth FundDepartment for International Development, UK GovernmentQueen Elizabeth Diamond Jubilee TrustUnited States Agency for International DevelopmentWorld Health Organization 001
6 · The paper itself

Abstract

Trachoma is targeted for elimination as a public health problem worldwide by 2030. In Nigeria, elimination activities are implemented at the local government area (LGA) level. They started in 2002 by conducting baseline population-based prevalence surveys (PBPSs), which continued in a systematic manner with engagement from the Global Trachoma Mapping Project in 2013, and subsequently Tropical Data. The results led to the development of Nigeria's first trachoma action plan and its subsequent revision with additional information. Following 449 baseline PBPSs, 122 LGAs had an active trachoma prevalence above the elimination threshold, requiring interventions, while 231 LGAs required community-based interventions for trichiasis management. By 2021, >34 million antibiotic treatments had been provided in 104 LGAs, with 89 LGAs eliminating active trachoma. Nationally, water and sanitation coverages increased by 3% and 18%, respectively, in 7 y. Systematic trichiasis case finding and management were carried out in 231 LGAs, resulting in the management of 102 527 people. Fifty-four LGAs decreased trichiasis prevalence unknown to the health system to <0.2% in persons ≥15 y of age. Where this elimination prevalence threshold was reached, trichiasis services were transitioned to routine eye/healthcare systems. Such progress relied on strong leadership and coordination from the national trachoma program and tremendous support provided by partners. Attaining elimination of trachoma as a public health problem in Nigeria by 2030 is feasible if funding support is sustained.

Indexed as

Anti-Bacterial AgentsDisease EradicationSanitationTrachomaTrichiasisAdolescentChildChild, PreschoolHumansLocal GovernmentNigeriaPrevalencePublic HealthAnti-Bacterial Agentseliminationneglected tropical diseasesNigeriatrachomatrichiasis

Identifiers

PMID38815996
PMCPMC11697179

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.